CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- SC 13G/A Stake Amended Statement of Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Planned sale EVP, Chief Financial Officer sold 77,550 shares at $13.52 ($1,048,119)
- 4 Option exercise Executive VP Global Operations acquired 77,802 shares (option exercise)
- 4 Planned sale Exec. VP, European Commercial sold 48,629 shares at $13.52 ($657,240)
- 4 Planned sale See "Remarks" sold 1,427 shares at $13.52 ($19,286)
- 4 Open-market sale EVP, International Markets sold 100,000 shares at $13.52 ($1,352,090)
- 4 Option exercise Chief Accounting Officer acquired 3,564 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale See "Remarks" sold 3,532 shares at $13.37 ($47,234)
- 4 Derivatives Options or other derivatives
Page 17 of 128 · 2,555 filings